NFKB1 and leukemia: Inactivation or silencing of NF-kB diminished, whereas exogenous expressed NF-kB increased promoter activity and gene expression of DNMT1 in human leukemia cells demonstrating nucleolin-NF-kB-DNMT1 axis as a new molecular pathway implicated in leukemogenesis [52].